---
figid: PMC4651701__nihms724421f1
figlink: /pmc/articles/PMC4651701/figure/F1/
number: F1
caption: IL4 induces heterodimerization of the IL4Rα and γC subunits to form the type
  I IL4 receptor in hematopoietic cells including lymphocytes (depicted). This results
  in the activation of JAK proteins. The two main pathways activated after the phosphorylation
  of JAKs in response to IL4 in immune cells are the IRS/PI3K/AKT pathway and the
  JAK/STAT6 pathway. Activation of these pathways in lymphocytes results in the transcription
  of IL4 responsive genes and the promotion of pro-growth phenotypes. IL4 has also
  been shown to activate mTOR in T lymphocytes for the regulation of differentiation.
  Some non-hematopoietic cells including epithelial cancer cells can express the type
  II IL4R, consisting of the IL4Rα and IL13Rα1 subunits. IL4 directly promotes pro-growth
  and pro-metastatic phenotypes downstream of the type II IL4R in epithelial cancer
  cells through several signaling pathways including PI3K/AKT, MAPK/ERK, JAK/STAT6,
  and mTOR.
pmcid: PMC4651701
papertitle: Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.
reftext: Katherine Venmar Bankaitis, et al. Clin Exp Metastasis. ;32(8):847-856.
pmc_ranked_result_index: '3769'
pathway_score: 0.9431632
filename: nihms724421f1.jpg
figtitle: Targeting IL4/IL4R for the treatment of epithelial cancer metastasis
year: ''
organisms: Homo sapiens
ndex: 934e1d87-df02-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4651701__nihms724421f1.html
  '@type': Dataset
  description: IL4 induces heterodimerization of the IL4Rα and γC subunits to form
    the type I IL4 receptor in hematopoietic cells including lymphocytes (depicted).
    This results in the activation of JAK proteins. The two main pathways activated
    after the phosphorylation of JAKs in response to IL4 in immune cells are the IRS/PI3K/AKT
    pathway and the JAK/STAT6 pathway. Activation of these pathways in lymphocytes
    results in the transcription of IL4 responsive genes and the promotion of pro-growth
    phenotypes. IL4 has also been shown to activate mTOR in T lymphocytes for the
    regulation of differentiation. Some non-hematopoietic cells including epithelial
    cancer cells can express the type II IL4R, consisting of the IL4Rα and IL13Rα1
    subunits. IL4 directly promotes pro-growth and pro-metastatic phenotypes downstream
    of the type II IL4R in epithelial cancer cells through several signaling pathways
    including PI3K/AKT, MAPK/ERK, JAK/STAT6, and mTOR.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - MAPK1
  - AKT1
  - AKT2
  - IL4R
  - MAPK3
  - AKT3
  - MTOR
  - TYK2
  - PIK3R4
  - IL13RA1
  - JAK3
  - PIK3R5
  - PIK3CG
  - PIK3CA
  - IL4
  - PIK3CD
  - STAT6
  - IRS1
  - PIK3CB
  - JAK2
  - JAK1
  - PIK3R3
  - IRS2
  - glucose
  - glutamine
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IL4R
  symbol: IL4R
  source: hgnc_symbol
  hgnc_symbol: IL4R
  entrez: '3566'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Tyk2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: IL13RA1
  symbol: IL13RA1
  source: hgnc_symbol
  hgnc_symbol: IL13RA1
  entrez: '3597'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IL4
  symbol: IL4
  source: hgnc_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: IRS1/2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: JAK1/2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK1/2
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: IRS1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
chemicals:
- word: glucose
  source: MESH
  identifier: D005947
- word: glutamine
  source: MESH
  identifier: D005973
diseases: []
figid_alias: PMC4651701__F1
redirect_from: /figures/PMC4651701__F1
figtype: Figure
---
